نتایج جستجو برای: fk506

تعداد نتایج: 2042  

2016
Dahae Lee Ki Sung Kang Jae Sik Yu Jung-Yoon Woo Gwi Seo Hwang Dae-Woon Eom Seung-Hoon Baek Hye Lim Lee Ki Hyun Kim Noriko Yamabe

BACKGROUND Compound FK506 is an immunosuppressant agent that is frequently used to prevent rejection of solid organs upon transplant. However, nephrotoxicity due to apoptosis and inflammatory response mediated by FK506 limit its usefulness. In this study, the protective effect of Korean Red Ginseng (KRG) against FK506-induced damage in LLC-PK1 pig kidney epithelial cells was investigated. MET...

Journal: :The Journal of clinical investigation 1996
J B Redmon L K Olson M B Armstrong M J Greene R P Robertson

FK506 (tacrolimus) is an immunosuppressive drug which interrupts Ca2+-calmodulin-calcineurin signaling pathways in T lymphocytes, thereby blocking antigen activation of T cell early activation genes. Regulation of insulin gene expression in the beta cell may also involve Ca2+-signaling pathways and FK506 has been associated with insulin-requiring diabetes mellitus during clinical use. The purpo...

2016
Xiujin Shen Hong Jiang Meike Ying Zhoutao Xie Xiayu Li Haibing Wang Jie Zhao Chuan Lin Yucheng Wang Shi Feng Jia Shen Chunhua Weng Weiqiang Lin Huiping Wang Qin Zhou Yan Bi Meng Li Lingyan Wang Tongyu Zhu Xiaoru Huang Hui-Yao Lan Jing Zhou Jianghua Chen

Podocyte injury and the appearance of proteinuria are features of minimal-change disease (MCD). Cyclosporin A (CsA) and tacrolimus (FK506) has been reported to reduce proteinuria in patients with nephrotic syndrome, but mechanisms remain unknown. We, therefore, investigated the protective mechanisms of CsA and FK506 on proteinuria in a rat model of MCD induced by puromycin aminonucleoside (PAN)...

Journal: :The Journal of biological chemistry 2010
Dusan Goranovic Gregor Kosec Peter Mrak Stefan Fujs Jaka Horvat Enej Kuscer Gregor Kopitar Hrvoje Petkovic

FK506 (tacrolimus) is a secondary metabolite with a potent immunosuppressive activity, currently registered for use as immunosuppressant after organ transplantation. FK506 and FK520 are biogenetically related natural products that are synthesized by combined polyketide synthase/nonribosomal peptide synthetase systems. The entire gene cluster for biosynthesis of FK520 from Streptomyces hygroscop...

2013
Adam C. Jones Bertolt Gust Andreas Kulik Lutz Heide Mark J. Buttner Mervyn J. Bibb

We describe a procedure for the conjugative transfer of phage P1-derived Artificial Chromosome (PAC) library clones containing large natural product gene clusters (≥70 kilobases) to Streptomyces coelicolor strains that have been engineered for improved heterologous production of natural products. This approach is demonstrated using the gene cluster for FK506 (tacrolimus), a clinically important...

Journal: :Cell 1995
Andrew M. Cameron Joseph P. Steiner A.Jane Roskams Siraj M. Ali Gabriele V. Ronnettt Solomon H. Snyder

The immunosuppressant drug FK506 binds to the immunophilin protein FKBP12 and inhibits its prolyl isomerase activity. Immunosuppressive actions, however, are mediated via an FK506-FKBP12 inhibition of the Ca(2+)-activated phosphatase calcineurin. Physiologic cellular roles for FKBP12 have remained unclear. FKBP12 is physically associated with the RyR and IP3R Ca2+ channels in the absence of FK5...

Journal: :Molecular medicine 1996
J P Steiner T M Dawson M Fotuhi S H Snyder

BACKGROUND The immunophilins are proteins that mediate actions of immunosuppressant drugs such as FK506 and cyclosporin A by binding to calcineurin, inhibiting its phosphatase activity, and increasing the phosphorylation level of transcription factors required for interleukin 2 formation. Though concentrations in the brain greatly exceed levels in immune tissues, no function has been previously...

Journal: :Blood 1992
R J Arceci K Stieglitz B E Bierer

The multidrug-resistant (MDR) phenotype is characterized in vitro by the resistance displayed by cell lines to a broad spectrum of natural product cytotoxic agents. This high level of cross-resistance is due to the increased expression of a membrane glycoprotein termed P-glycoprotein. Encoded in humans by the mdr1 gene, P-glycoprotein functions as an energy-dependent efflux pump of these cytoto...

2014
Terry D Hinds Lance A Stechschulte Fadel Elkhairi Edwin R Sanchez

The immunosuppressive ligand FK506 and the FK506-binding protein FKBP52 are stimulatory to glucocorticoid receptor (GR) activity. Here, we explore the underlying mechanism by comparing GR activity and phosphorylation status in response to FK506 and the novel nonimmunosuppressive ligand timcodar (VX-853) and in the presence and absence of FKBP52 and the closely related protein FKBP51. Using mous...

Journal: :The European respiratory journal 2006
J Nagano K Iyonaga K Kawamura A Yamashita H Ichiyasu T Okamoto M Suga Y Sasaki H Kohrogi

Idiopathic pulmonary fibrosis has a poor prognosis and few efficacious treatments. The immunosuppressant cyclosporin A has been shown to inhibit tumour growth factor (TGF)-beta-induced collagen deposition in vitro, and is widely used in Japan as a potent antifibrotic agent. Tacrolimus (FK506) is another attractive immunosuppressant, which may be useful in the treatment of pulmonary fibrosis. Th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید